New evidence-based guideline for HPV testing in head and neck cancers

Mary R. Schwartz, Justin A. Bishop

Research output: Contribution to journalArticle

Abstract

It is now well established that a subset of head and neck carcinomas is defined by their association with high-risk types of human papillomavirus (HPV). These HPV-driven head and neck carcinomas are characterized by distinct histologic and clinical features, including an excellent prognosis and response to therapy. Although the recognition of this subtype of head and neck cancer has been a significant advancement in head and neck oncology, confusion has persisted regarding why, when, and how HPV testing should be carried out. The College of American Pathologists (CAP) recently published evidence-based guidelines addressing HPV testing in head and neck carcinomas, offering much-needed clarification on a complicated issue. This review will detail each CAP guideline while also explaining the rationale and methods for their creation.

Original languageEnglish (US)
JournalJournal of the American Society of Cytopathology
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Head and Neck Neoplasms
Neck
Head
Guidelines
Carcinoma
Pathologists
Therapeutics

Keywords

  • College of American Pathologists
  • Evidence-based guideline
  • Guideline
  • Head and neck cancer
  • HPV testing
  • Oropharyngeal squamous cell carcinoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

@article{c52bdf4d770b49b6b995076995796ecf,
title = "New evidence-based guideline for HPV testing in head and neck cancers",
abstract = "It is now well established that a subset of head and neck carcinomas is defined by their association with high-risk types of human papillomavirus (HPV). These HPV-driven head and neck carcinomas are characterized by distinct histologic and clinical features, including an excellent prognosis and response to therapy. Although the recognition of this subtype of head and neck cancer has been a significant advancement in head and neck oncology, confusion has persisted regarding why, when, and how HPV testing should be carried out. The College of American Pathologists (CAP) recently published evidence-based guidelines addressing HPV testing in head and neck carcinomas, offering much-needed clarification on a complicated issue. This review will detail each CAP guideline while also explaining the rationale and methods for their creation.",
keywords = "College of American Pathologists, Evidence-based guideline, Guideline, Head and neck cancer, HPV testing, Oropharyngeal squamous cell carcinoma",
author = "Schwartz, {Mary R.} and Bishop, {Justin A.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.jasc.2018.06.001",
language = "English (US)",
journal = "Journal of the American Society of Cytopathology",
issn = "2213-2945",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - New evidence-based guideline for HPV testing in head and neck cancers

AU - Schwartz, Mary R.

AU - Bishop, Justin A.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - It is now well established that a subset of head and neck carcinomas is defined by their association with high-risk types of human papillomavirus (HPV). These HPV-driven head and neck carcinomas are characterized by distinct histologic and clinical features, including an excellent prognosis and response to therapy. Although the recognition of this subtype of head and neck cancer has been a significant advancement in head and neck oncology, confusion has persisted regarding why, when, and how HPV testing should be carried out. The College of American Pathologists (CAP) recently published evidence-based guidelines addressing HPV testing in head and neck carcinomas, offering much-needed clarification on a complicated issue. This review will detail each CAP guideline while also explaining the rationale and methods for their creation.

AB - It is now well established that a subset of head and neck carcinomas is defined by their association with high-risk types of human papillomavirus (HPV). These HPV-driven head and neck carcinomas are characterized by distinct histologic and clinical features, including an excellent prognosis and response to therapy. Although the recognition of this subtype of head and neck cancer has been a significant advancement in head and neck oncology, confusion has persisted regarding why, when, and how HPV testing should be carried out. The College of American Pathologists (CAP) recently published evidence-based guidelines addressing HPV testing in head and neck carcinomas, offering much-needed clarification on a complicated issue. This review will detail each CAP guideline while also explaining the rationale and methods for their creation.

KW - College of American Pathologists

KW - Evidence-based guideline

KW - Guideline

KW - Head and neck cancer

KW - HPV testing

KW - Oropharyngeal squamous cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=85049599361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049599361&partnerID=8YFLogxK

U2 - 10.1016/j.jasc.2018.06.001

DO - 10.1016/j.jasc.2018.06.001

M3 - Article

C2 - 31043288

AN - SCOPUS:85049599361

JO - Journal of the American Society of Cytopathology

JF - Journal of the American Society of Cytopathology

SN - 2213-2945

ER -